Criteria to define response to therapy in paediatric rheumatic diseases. - Wikidata - wikimedia - TriplyDB

Criteria to define response to therapy in paediatric rheumatic diseases.

Criteria to define response to therapy in paediatric rheumatic diseases.

http://www.wikidata.org/entity/Q37811971

about

Dynamic knee joint function in children with juvenile idiopathic arthritis (JIA).Exercise in children with joint hypermobility syndrome and knee pain: a randomised controlled trial comparing exercise into hypermobile versus neutral knee extension.Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.International consensus for provisions of quality-driven care in childhood-onset systemic lupus erythematosus.Disease activity measures in paediatric rheumatic diseases Management considerations for childhood-onset systemic lupus erythematosus patients and implications on therapy.Time to focus on outcome assessment tools for childhood vasculitis.Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF).2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatri 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology Biologic agents therapy for Saudi children with rheumatic diseases: indications and safety.

P2860

Q35232922-D632AD80-E705-44FE-A725-2E6622C712C3 Q37116072-6275AF2A-4762-422C-8D8E-87AC3FA14B31 Q37388175-DF9F76D1-9CBE-4816-B87D-793667B7565F Q38086806-17FE1BC0-ABDE-4A66-BC84-86FDCF6D7975 Q38148751-BE0609A2-D71C-402B-92ED-815C88C87401 Q38640910-9E1E47D8-7925-4628-A670-605A334FAB64 Q38695974-5235E7F5-947B-412F-9817-503C5C79CA97 Q38914751-780D46C4-367D-44E4-986D-61A0C1D241C8 Q46815762-F4A98DE1-DD87-4291-A7E2-934FD0ECA67F Q47924181-8C7B163B-B118-4AEF-893E-B637A9A10750 Q51146578-CD655309-237A-47ED-9DCD-90C870065AB2

P2860

Criteria to define response to therapy in paediatric rheumatic diseases.

http://www.wikidata.org/entity/Q37811971

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Criteria to define response to therapy in paediatric rheumatic diseases.

@en

Criteria to define response to therapy in paediatric rheumatic diseases.

@nl

type

label

Criteria to define response to therapy in paediatric rheumatic diseases.

@en

Criteria to define response to therapy in paediatric rheumatic diseases.

@nl

prefLabel

Criteria to define response to therapy in paediatric rheumatic diseases.

@en

Criteria to define response to therapy in paediatric rheumatic diseases.

@nl

P1433

Q37811971-0F95D07C-E7E1-41C1-AEDF-6F4CAA1AF93E

P1476

Q37811971-1A7FD05F-69B3-4705-BB29-C424EC17937D

P2093

Q37811971-08A49388-39F5-443B-ACE6-2EF8A2B460B8

Q37811971-1C54BFE5-9A66-4BB5-AEEB-4DCCF772BA76

Q37811971-21E12DF9-04F3-43E9-9FAC-E7224F73CCDF

Q37811971-23A85610-A169-4491-B12F-3EE6C5E9C4B7

Q37811971-637AFA5A-E26B-49DE-9D01-8BB23821D4BB

Q37811971-77342181-7D1D-426A-A45E-197F3FC709AD

Q37811971-77A5DECE-31F3-435D-845D-D4EA94C65C19

Q37811971-811A3890-E4C6-4F1C-A896-B556BF2F09F5

P2860

Q37811971-038C2650-CDAC-453C-9348-398569B4039B

Q37811971-0ECA136D-B03E-49E3-BB82-0B9CC59F727A

Q37811971-102A83AE-84A1-440A-800E-A67B6B0C7BAF

Q37811971-1214DEE3-A201-4CBF-B8EB-DDB525E58813

Q37811971-15D9AAF3-C870-46F8-896D-FEE0B21EA459

Q37811971-1E76ACB9-75CF-4F56-BB9F-F203544697E1

Q37811971-3AF52553-46EE-4C7B-829B-6C55D3A746FD

Q37811971-3B683C7D-4FD3-4FBB-86A5-984F9AE363DD

Q37811971-4AACE315-5674-4453-84A4-10C7AACE508A

Q37811971-4AB9AFF5-BCDC-4840-8EBD-2F880007DE2A

P2888

Q37811971-D0897D1E-677F-40AE-BF4D-6A4A4D9990D8

P304

Q37811971-67406498-CDE3-45E8-A82C-749D8DD3A223

P31

Q37811971-175BD637-5F5A-45EE-813B-3CA771854093

P356

Q37811971-B36E414D-B024-4318-BCF5-3C6029985E51

P478

Q37811971-0B430E3C-994B-4C42-B6CF-31D814FCD029

P50

Q37811971-412DDC17-66FA-4F93-BDA2-82B0322C7B45

Q37811971-A0021CB1-6D0E-42E0-BFF8-8EBC79E60BD5

P577

Q37811971-023653E3-A62C-44C5-9464-4AF5D3127B81

P5875

Q37811971-B0537CE1-5F42-4601-9CCB-D8632ACBDAF6

P698

Q37811971-5F437F74-EB18-4D31-9E98-DAFA2BB3CA5F

P356

S00228-010-0937-8

P1433

European Journal of Clinical Pharmacology

P1476

Criteria to define response to therapy in paediatric rheumatic diseases.

@en

P2093

Alberto Martini

http://www.w3.org/2001/XMLSchema#string

Angela Pistorio

http://www.w3.org/2001/XMLSchema#string

Angelo Ravelli

http://www.w3.org/2001/XMLSchema#string

Clara Malattia

http://www.w3.org/2001/XMLSchema#string

Dinara Guseinova

http://www.w3.org/2001/XMLSchema#string

Giovanni Filocamo

http://www.w3.org/2001/XMLSchema#string

Paediatric Rheumatology International Trials Organisation (PRINTO)

http://www.w3.org/2001/XMLSchema#string

Rachana Hasija

http://www.w3.org/2001/XMLSchema#string

P2860

Coefficient alpha and the internal structure of tests

Redundancy of conventional articular response variables used in juvenile chronic arthritis clinical trials.

Clinical trials, consensus conferences, and clinical practice.

Use of unlabelled and off licence drugs in children. Use of unlicensed drugs may be recommended in guidelines.

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

Correlation between conventional disease activity measures in juvenile chronic arthritis.

Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group

International consensus on preliminary definitions of improvement in adult and juvenile myositis.

International research networks in pediatric rheumatology: the PRINTO perspective.

P2888

s00228-010-0937-8

P304

125-131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00228-010-0937-8

http://www.w3.org/2001/XMLSchema#string

P478

67 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Erkan Demirkaya

Nicolino Ruperto

P577

2010-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49632480

http://www.w3.org/2001/XMLSchema#string

P698

21103985

http://www.w3.org/2001/XMLSchema#string